Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is providing ...
There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...
ABS (American Bureau of Shipping) Type Approval for 750-841 Series Ethernet enabled programmable controller and the 758 Series Industrial PC – certifies WAGO’s I/O and controller products for use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback